Condition: Portal Hypertension · Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
A minimally invasive procedure to directly assess portal pressure gradient under endoscopic ultrasound guidance (EUS-PPG) has become available and initial data have proved the technique to be safe. Aims of our proposal are: (i) to assess performance of EUS-PPG as compared to HVPG in evaluating hemodynamic response to non selective betablockers (NSBBs) in a large cohort of patients with CSPH;(ii) identification of markers of hemodynamic response(iii) identification of factors potentially affecting the accuracy of PPG measurement.
This description comes directly from the study's public registry record.
Francesco Santopaolo, MD · +393492754288 · francesco.santopaolo@policlinicogemelli.it
Elisabetta Creta, SC · elisabetta.creta@policlinicogemelli.it
Always discuss trial participation with your own doctor first.
| Policlinico Gemelli IRCCS | Roma, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06266260